"Hydroxycholesterols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cholesterol which is substituted by a hydroxy group in any position.
| Descriptor ID |
D006888
|
| MeSH Number(s) |
D04.210.500.247.222.284.800.500 D04.210.500.247.808.197.800.500 D10.570.938.208.825.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hydroxycholesterols".
Below are MeSH descriptors whose meaning is more specific than "Hydroxycholesterols".
This graph shows the total number of publications written about "Hydroxycholesterols" by people in this website by year, and whether "Hydroxycholesterols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hydroxycholesterols" by people in Profiles.
-
27-Hydroxycholesterol acts on estrogen receptor a expressed by POMC neurons in the arcuate nucleus to modulate feeding behavior. Sci Adv. 2024 Jul 12; 10(28):eadi4746.
-
Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021 08 24; 12(1):5103.
-
27-Hydroxycholesterol Promotes Adiposity and Mimics Adipogenic Diet-Induced Inflammatory Signaling. Endocrinology. 2019 10 01; 160(10):2485-2494.
-
27-Hydroxycholesterol, an Endogenous SERM, and Risk of Fracture in Postmenopausal Women: A Nested Case-Cohort Study in the Women's Health Initiative. J Bone Miner Res. 2019 01; 34(1):59-66.
-
The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun. 2017 10 11; 8(1):864.
-
CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer. Cancer Res. 2017 04 01; 77(7):1662-1673.
-
Cholesterol and breast cancer pathophysiology. Trends Endocrinol Metab. 2014 Dec; 25(12):649-55.
-
The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer. Climacteric. 2014 Dec; 17 Suppl 2:60-5.
-
From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs). Steroids. 2014 Nov; 90:30-8.
-
Obesity, cholesterol metabolism, and breast cancer pathogenesis. Cancer Res. 2014 Sep 15; 74(18):4976-82.